Brussels, March 24, 2014: The Neuromed-led project “Neurobiotech”, aimed at setting up an International Research and Innovation Community on Neuroscience, will be launched on April 2nd at the European Parliament.
Neuromed and ISC are hosting the press conference to introduce media and interested stakeholders to the project, Neurobiotech. In addition, the press conference will brief European media about the R&D and Innovation capabilities of Neuromed.
Neuromed is a research centre recognized by the Italian Ministry of Health as a highly qualified research and clinical organization specialized in Neuroscience in cooperation with the Molise Regional Government, the Italian National Research Council, the Universities of Rome Sapienza, Tor Vergata and Molise. Several foreign research centres and companies have also agreed to participate in the cluster.
With Horizon 2020 as a platform, Neurobiotech aims to combine research, innovation, technology transfer and training to focus on the common goal of sharing and integrating knowledge, stimulating research activities in the field of Neuroscience applying a multidisciplinary approach. Hence, research, exchange of know-how, intensive interaction and the joint use of infrastructures, facilities and services with high added value are encouraged.
Speakers at the Press Conference will include:
As a partner of the project, the Molise Regional Government will consider the proposal as a pilot project for the definition of the strategic framework of the regional cohesion policy. Within the framework of the Neurobiotech cluster, the Molise region has set aside financial resources for companies and research centres wishing to invest in Molise, therefore, contributing to a knowledge-based economy. It will be the first experiment of integrating European resources managed both by the European Commission and Local Authorities.
The research and innovation activities will focus on the development of the following fields:
• Cutting-edge Neuroscience and Biotechnology;
• Stem cells, Tissue engineering and Cell biology;
• Nanotechnology and Biomaterials;
• Biomechanics and Robotics;
• Human Brain Interface;
• Telemedicine and Telediagnostics;
• Advanced Imaging.
The press conference will be an excellent platform for media and interested stakeholders to learn about the R&D and Innovation capabilities of Neuromed in general, and Neurobiotech specifically. Media will also have the opportunity to ask questions and conduct interviews.
Date and Time: 2nd April, 14.00 - 15.00
Location: European Parliament, Room ASP 5G2
To register: http://iscintelligence.com/event.php?id=161
ISC Intelligence in Science
Tel: +32 2 8888 100
ISC Intelligence in Science
Phone: +32 2 8888 100
Mob: +32 487 163 107
Assistance, Research, Training & Education
The Neuromed Institute is a center dedicated exclusively to monospecialist Neurology, Neurosurgery and Neurorehabilitation. At the clinic, specialists of the afore mentioned disciplines work in synergy and conduct collaborative scientific research activities.
Further information: http://www.neuromed.it/?lang=en
Horizon 2020 is the biggest EU Research and Innovation programme ever with nearly €80 billion of funding available over 7 years (2014 to 2020) – in addition to the private investment that this money will attract. It promises more breakthroughs, discoveries and world-firsts by taking great ideas from the lab to the market.
Further information: http://ec.europa.eu/programmes/horizon2020/en/what-horizon-2020